David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.52B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.43B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$798M |
| 4 |
Amazon
AMZN
|
+$646M |
| 5 |
Texas Instruments
TXN
|
+$619M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.31B |
| 2 |
Broadcom
AVGO
|
+$1.01B |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$863M |
| 4 |
Western Digital
WDC
|
+$595M |
| 5 |
Meta Platforms (Facebook)
META
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.6% |
| 2 | Consumer Discretionary | 9.12% |
| 3 | Healthcare | 7.62% |
| 4 | Industrials | 7.14% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Keros Therapeutics
KROS
$220M
| $15.4M | 0.01% |
755,473
-575,952
| -43% | -$10.1M |
|
1327
Ashland
ASH
$3.4B
| $15.4M | 0.01% |
261,828
-286,582
| -52% | -$15.1M |
|
1328
Royal Gold
RGLD
$22.5B
| $15.3M | 0.01% |
68,883
+33,900
| +97% | +$6.72M |
|
1329
Imperial Oil
IMO
$63.6B
| $15.3M | 0.01% |
177,028
-26,812
| -13% | -$2.44M |
|
|
GPAT
1330
GP-Act III Acquisition Corp
GPAT
| $15.2M | 0.01% |
1,423,125
| – | – |
|
1331
Avery Dennison
AVY
$13.8B
| $15.2M | 0.01% |
83,630
-15,867
| -16% | -$2.74M |
|
1332
CALL
SLB Ltd
SLB
$79.5B
| $15.2M | 0.01% |
395,700
+14,500
| +4% | +$526K |
|
1333
Green Plains
GPRE
$1.04B
| $15.2M | 0.01% |
1,547,430
+319,602
| +26% | +$3.22M |
|
1334
GigaCloud Technology
GCT
$1.86B
| $15.2M | 0.01% |
386,019
-37,479
| -9% | -$1.24M |
|
1335
Acadia Healthcare
ACHC
$2.85B
| $15.2M | 0.01% |
1,068,164
-1,130,925
| -51% | -$21.4M |
|
1336
Wingstop
WING
$3.06B
| $15.2M | 0.01% |
63,542
+17,685
| +39% | +$4.38M |
|
|
CRCL
1337
PUT
Circle Internet Group
CRCL
$22.8B
| $15.1M | 0.01% |
190,000
+70,000
| +58% | +$7.23M |
|
|
VTYX
1338
DELISTED
Ventyx Biosciences
VTYX
| $15M | 0.01% |
1,665,474
+1,142,786
| +219% | +$8.54M |
|
1339
CALL
Wayfair
W
$14.2B
| $15M | 0.01% |
149,700
-2,600
| -2% | -$250K |
|
1340
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $15M | 0.01% |
33,100
-2,500
| -7% | -$1.08M |
|
1341
Aon
AON
$75.1B
| $15M | 0.01% |
42,435
-36,805
| -46% | -$12.9M |
|
1342
Bruker
BRKR
$8.69B
| $15M | 0.01% |
317,508
+111,591
| +54% | +$4.72M |
|
1343
Amphastar Pharmaceuticals
AMPH
$937M
| $14.9M | 0.01% |
557,066
+39,844
| +8% | +$1.03M |
|
1344
Universal Display
OLED
$3.99B
| $14.9M | 0.01% |
127,587
+118,350
| +1,281% | +$15.3M |
|
1345
Gold Royalty Corp
GROY
$790M
| $14.8M | 0.01% |
3,671,513
+1,899,373
| +107% | +$7.27M |
|
1346
PUT
Cameco
CCJ
$46.8B
| $14.8M | 0.01% |
162,100
-102,800
| -39% | -$9.26M |
|
1347
Mirion Technologies
MIR
$3.71B
| $14.7M | 0.01% |
629,175
-610,386
| -49% | -$15.2M |
|
1348
FIGS
FIGS
$2.53B
| $14.7M | 0.01% |
1,295,986
+963,349
| +290% | +$9.02M |
|
1349
Credicorp
BAP
$30.4B
| $14.7M | 0.01% |
51,284
+41,518
| +425% | +$11M |
|
|
EVAC
1350
EQV Ventures Acquisition Corp II
EVAC
$601M
| $14.6M | 0.01% |
1,460,600
| – | – |
|
Similar funds
David Shaw's Q4 2025 Portfolio in Review
As of Q4 2025, David Shaw held 5,141 positions worth $182B, up 3% from $177B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2025 filing shows 639 new, 1,734 increased, 1,574 reduced and 583 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M. The largest sale was Micron Technology, an estimated $1.31B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,175,000 shares worth $805M.
- David Shaw added most to Advanced Micro Devices in Q4 2025, an estimated $1.52B increase.
- David Shaw's biggest Q4 2025 reduction was Micron Technology, cutting an estimated $1.31B.
- David Shaw fully exited Vanguard Short-Term Corporate Bond ETF in Q4 2025, selling an estimated $499M.
- David Shaw's ten largest holdings make up 12% of its $182B portfolio in Q4 2025.
- David Shaw opened 639 new positions and closed 583 in Q4 2025.
- David Shaw's portfolio value rose 3% quarter-over-quarter to $182B.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.